Pomerantz LLP has initiated a class action lawsuit against Ardent Health, Inc., alleging securities fraud and unlawful business practices stemming from the company's November 2025 financial disclosures. The filing followed Ardent's announcement of a $43 million revenue decrease attributed to a new accounting system that uncovered higher accounts receivable reserves, prompting the company to simultaneously cut EBITDA guidance by $57.5 million and increase professional liability reserves by $54 million.
The cumulative impact of these disclosures triggered a sharp market reaction, with Ardent Health's stock declining 33.81% following the announcement. Shareholders who experienced losses during the relevant period are eligible to participate in the litigation at no upfront cost.
Investors seeking to join the class action must act before the March 9, 2026 deadline. The lawsuit represents an attempt to recover damages on behalf of shareholders who held Ardent Health securities during the period when the accounting and financial issues were not publicly disclosed.